620 related articles for article (PubMed ID: 26910734)
21. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.
Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV
J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858
[TBL] [Abstract][Full Text] [Related]
22. Deficits in endogenous adenosine formation by ecto-5'-nucleotidase/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis.
Oliveira L; Correia A; Cristina Costa A; Guerra-Gomes S; Ferreirinha F; Magalhães-Cardoso MT; Vilanova M; Correia-de-Sá P
Mediators Inflamm; 2015; 2015():460610. PubMed ID: 25691808
[TBL] [Abstract][Full Text] [Related]
23. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.
Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S
Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338
[TBL] [Abstract][Full Text] [Related]
24. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.
Deaglio S; Dwyer KM; Gao W; Friedman D; Usheva A; Erat A; Chen JF; Enjyoji K; Linden J; Oukka M; Kuchroo VK; Strom TB; Robson SC
J Exp Med; 2007 Jun; 204(6):1257-65. PubMed ID: 17502665
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides.
Morabito L; Montesinos MC; Schreibman DM; Balter L; Thompson LF; Resta R; Carlin G; Huie MA; Cronstein BN
J Clin Invest; 1998 Jan; 101(2):295-300. PubMed ID: 9435300
[TBL] [Abstract][Full Text] [Related]
26. Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.
El-Tayeb A; Iqbal J; Behrenswerth A; Romio M; Schneider M; Zimmermann H; Schrader J; Müller CE
J Med Chem; 2009 Dec; 52(23):7669-77. PubMed ID: 19580286
[TBL] [Abstract][Full Text] [Related]
27. Extracellular ATP Selectively Upregulates Ecto-Nucleoside Triphosphate Diphosphohydrolase 2 and Ecto-5'-Nucleotidase by Rat Cortical Astrocytes In Vitro.
Brisevac D; Adzic M; Laketa D; Parabucki A; Milosevic M; Lavrnja I; Bjelobaba I; Sévigny J; Kipp M; Nedeljkovic N
J Mol Neurosci; 2015 Nov; 57(3):452-62. PubMed ID: 26080748
[TBL] [Abstract][Full Text] [Related]
28. Ecto-5'-nucleotidase (CD73) is involved in chronic cerebral hypoperfusion-induced white matter lesions and cognitive impairment by regulating glial cell activation and pro-inflammatory cytokines.
Hou X; Liang X; Chen JF; Zheng J
Neuroscience; 2015 Jun; 297():118-26. PubMed ID: 25805696
[TBL] [Abstract][Full Text] [Related]
29. Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.
Mandapathil M; Szczepanski MJ; Szajnik M; Ren J; Lenzner DE; Jackson EK; Gorelik E; Lang S; Johnson JT; Whiteside TL
Clin Cancer Res; 2009 Oct; 15(20):6348-57. PubMed ID: 19825957
[TBL] [Abstract][Full Text] [Related]
30. CD73 expression on extracellular vesicles derived from CD4+ CD25+ Foxp3+ T cells contributes to their regulatory function.
Smyth LA; Ratnasothy K; Tsang JY; Boardman D; Warley A; Lechler R; Lombardi G
Eur J Immunol; 2013 Sep; 43(9):2430-40. PubMed ID: 23749427
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
32. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.
Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M
Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681
[TBL] [Abstract][Full Text] [Related]
33. Thyroid hormone stimulates 5'-ecto-nucleotidase of neonatal rat ventricular myocytes.
Carneiro-Ramos MS; da Silva VB; Coutinho MB; Battastini AM; Sarkis JJ; Barreto-Chaves ML
Mol Cell Biochem; 2004 Oct; 265(1-2):195-201. PubMed ID: 15543949
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway.
Mora-García ML; Ávila-Ibarra LR; García-Rocha R; Weiss-Steider B; Hernández-Montes J; Don-López CA; Gutiérrez-Serrano V; Titla-Vilchis IJ; Fuentes-Castañeda MC; Monroy-Mora A; Jave-Suárez LF; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
Cell Immunol; 2017 Oct; 320():46-55. PubMed ID: 28950987
[TBL] [Abstract][Full Text] [Related]
35. No correlation between CD73 expression and ecto-5'-nucleotidase activity on blood mononuclear cells in vitro. Evidence of CD73 (ecto-5'-nucleotidase) on blood mononuclear cells with distinct antigenic properties.
Christensen LD
APMIS; 1996 Feb; 104(2):126-34. PubMed ID: 8619914
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves.
Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684
[TBL] [Abstract][Full Text] [Related]
37. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia.
Synnestvedt K; Furuta GT; Comerford KM; Louis N; Karhausen J; Eltzschig HK; Hansen KR; Thompson LF; Colgan SP
J Clin Invest; 2002 Oct; 110(7):993-1002. PubMed ID: 12370277
[TBL] [Abstract][Full Text] [Related]
38. Indomethacin stimulates activity and expression of ecto-5'-nucleotidase/CD73 in glioma cell lines.
Bernardi A; Bavaresco L; Wink MR; Jacques-Silva MC; Delgado-Cañedo A; Lenz G; Battastini AM
Eur J Pharmacol; 2007 Aug; 569(1-2):8-15. PubMed ID: 17568578
[TBL] [Abstract][Full Text] [Related]
39. An overview of current therapeutic strategies for glioblastoma and the role of CD73 as an alternative curative approach.
Arab S; Hasannejad F
Clin Transl Oncol; 2022 May; 24(5):742-756. PubMed ID: 34792724
[TBL] [Abstract][Full Text] [Related]
40. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
